Nuevos alimentos. Aspectos científicos, tecnológicos y sociales
ALIMNOVA
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (10)
2022
-
Current evidence on the modulatory effects of food proteins and peptides in inflammation and gut microbiota
Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress (Elsevier), pp. 517-534
2021
-
Bioactive peptides against inflammatory intestinal disorders and obesity
Bioactive Food Components Activity in Mechanistic Approach (Elsevier), pp. 155-183
-
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract
Molecular Nutrition and Food Research, Vol. 65, Núm. 12
2020
-
Gastrointestinal Digestion of Food Proteins under the Effects of Released Bioactive Peptides on Digestive Health
Molecular Nutrition and Food Research, Vol. 64, Núm. 21
-
Serum adipokines as non-invasive biomarkers in Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
Therapeutic Advances in Gastroenterology, Vol. 12
-
Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease
Nutrients, Vol. 11, Núm. 11
-
Peptides encrypted in the human intestinal microbial-exoproteome as novel biomarkers and immunomodulatory compounds in the gastrointestinal tract
Journal of Functional Foods, Vol. 52, pp. 459-468
-
Role of food proteins and bioactive peptides in inflammatory bowel disease
Trends in Food Science and Technology, Vol. 88, pp. 194-206
2018
-
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease article
Mucosal Immunology, Vol. 11, Núm. 4, pp. 1114-1126